Cetuximab 5 mg/mL Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 5 mg/mL
Reference Brands: ERBITUX (USA/EU)
Category: Oncology Cancer Care
Cetuximab is a chimeric monoclonal antibody that targets the epidermal growth factor receptor (EGFR), blocking its activation and slowing cancer cell growth. It is used in the treatment of metastatic colorectal cancer and squamous cell carcinoma of the head and neck. Cetuximab enhances the effect of chemotherapy and radiation therapy by inhibiting tumor cell proliferation. Marketed mainly under the brand name Erbitux, it is administered intravenously under medical supervision.
Cetuximab — third party manufacturing & bulk supply
Cetuximab 5 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Cetuximab is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Cetuximab listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Cetuximab →Frequently Asked Questions
Cetuximab is used to treat certain types of cancer, including metastatic colorectal cancer and squamous cell carcinoma of the head and neck. It works by targeting the epidermal growth factor receptor (EGFR) on cancer cells, blocking their growth and proliferation. Cetuximab is often used in combination with chemotherapy or radiation therapy to enhance treatment effectiveness.
Cetuximab is made from a chimeric monoclonal antibody that specifically binds to the EGFR protein on the surface of cancer cells, inhibiting receptor activation and signaling pathways responsible for tumor growth.
The trade name of Cetuximab is Erbitux.
Cetuximab (Erbitux) is manufactured by Eli Lilly and Merck KGaA and distributed in multiple countries under regulatory approvals.
The generic name of Cetuximab is Cetuximab.
The brand name of Cetuximab is Erbitux.
Cetuximab is manufactured in the United States, Germany, and other approved facilities by Eli Lilly and Merck KGaA under strict GMP standards.
Related Products
Eribulin Mesylate
Strength:
0.44 mg/mL
Form: Injection
Reference Brands: HALAVEN (USA/EU)
View Details
Epcoritamab-Bysp
Strength:
4 mg/0.8 mL, 48 mg/0.8 mL
Form: Injection
Reference Brands: EPKINLY (USA)
View Details
Azacitidine Injection
Strength:
100 mg/vial
Form: Injectable
Reference Brands: Vidaza®(EU & US)
View Details
Bendamustine Hydrochloride
Strength:
25 mg/vial, 100 mg/vial
Form: Injection (powder for solution)
Reference Brands: Treanda®, Bendeka®(US), Levact®(EU)
View Details
Bortezomib 2 Mg Injection
Strength:
1 mg/vial, 3.5 mg/vial, 2 mg
Form: Injection (lyophilized powder for solution)
Reference Brands: Velcade® (US & EU), Bortecad (India)
View DetailsQuick Response Guaranteed | Verified Suppliers
